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Abstract 
Purpose: To investigate the expression of Myt272-3 recombinant protein and also to predict a possible 
protein vaccine candidate against Mycobacterium tuberculosis.  
Methods: Myt272-3 protein was expressed in pET30a+-Myt272-3 clone. The purity of the protein was 
determined using Dynabeads® His-Tag Isolation & Pulldown. Protein sequence was analysed in silico 
using bioinformatics software for the prediction of allergenicity, antigenicity, MHC-I and MHC-II binding, 
and B-cell epitope binding. 
Results: The candidate protein was a non-allergen with 15.19 % positive predictive value. It was also 
predicted to be antigenic, with binding affinity to MHC-I and MHC-II, as well as B-cell epitope binding. 
Conclusion: The predicted results obtained in this study provide a guide for practical design of a new 
tuberculosis vaccine. 
 
Keywords: Vaccine, Mycobacterium tuberculosis, Epitope prediction, Histocompatibility complexes 
 
Tropical Journal  of Pharmaceutical Research is indexed by Science Citation Index (SciSearch), Scopus, 
International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals 




Tuberculosis is a very serious infectious disease 
which primarily affects lungs, and is caused by 
Mycobacterium tuberculosis, an intracellular 
pathogen [1]. The global threat of tuberculosis, 
together with the emergence of multi-drug 
resistant strains of M. tuberculosis and co-
infection with human immunodeficiency virus 
(HIV), constitute significant challenges to 
researchers, physicians and patients [2]. The 
latent stage of tuberculosis represents an 
equilibrium state in which the host controls the 
infection but is unsuccessful in clearing it, 
thereby allowing the bacterial survival at 
relatively constant low levels [3]. According to a 
report by WHO in 2012, 8.6 million people 
developed tuberculosis and out of that figure, 1.3 
million people died as a result of the disease [4]. 
There is an urgent need of a new and improved 
vaccine against tuberculosis due to the variable 
and unreliable efficacy of Bacille Calmette-
Guerin (BCG), the current and sole vaccine in 
use, as well as the emergence of drug-resistant 
strains of the causative organism [5]. Efficient 
protection against tuberculosis is achieved in 
newborns by BCG, but unfortunately the vaccine 
does not prevent latent infection or reactivation of 
tuberculosis in adults [6]. In addition, BCG has 
shown protective efficacies in adult pulmonary 
tuberculosis, ranging from 0 to 80 per cent [7]. 
Identification of microbial components 
responsible for generation of immune responses 
is the first and most crucial step in the 
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development of new vaccines [8]. 
Immunoinformatics deals with the application of 
bioinformatics in immunology and is widely 
accepted due to its usefulness in the design of 
new vaccines through identification of T-cell 
epitope, B- cell epitopes and MHCs [9]. 
 
In this study, Myt272-3 protein was expressed, 
purified and characterized.  Immunoinformatics 
strategies were harnessed via software and 
programs; and antigenicity and epitope-based 
immunoinformatics studies were carried out 
using the expressed Myt272-3 protein so as to 
predict epitope-based information that can assist 




Bacterial strains and recombinant clone 
Myt272-3 
 
The bacterial strain BL21 (DE3) pLysS was 
obtained from Invitrogen (USA). The recombinant 
expressing vector (pET30a+-Myt272-3) used in 
this study was constructed in  the Molecular 
Bacteriology and Toxicology laboratory, Faculty 
of Science, University of Malaya. Construction of 
the clone involved shotgun cloning technique. 
 
Stability testing of the recombinant clone 
Myt272-3 
 
Plasmid stability of the clone was tested by the 
method described by Lanka and Barth with slight 
modification [10]. Myt272-3 cultures were grown 
in LB broth overnight at 37 °C. The clones were 
sub-cultured in LB broth and LB agar and were 
also incubated overnight; the sub-culturing 
protocol was carried out repeatedly (10 times). 
After the tenth and the final transfer into fresh LB 
broth and agar media, the plasmid DNA was 
extracted using NucleoSpin® Plasmid 
(Macherey-Nagel, Germany) based on the 
manufacturer's instructions. 
 
Restriction digestion analysis 
 
Restriction endonuclease digestion was carried 
out using two enzymes, Bam-HI-HF and KpnI-
HF. Double digestion was done with the two 
enzymes in order to release the insert. 
Restriction endonuclease digestion was done in 
compliance with the conditions stipulated by the 
supplier (New England Biolabs, USA). 
 
Protein expression, detection and purification 
 
The recombinant clones of (pET30a+-Myt272-3) 
were transformed into BL21 (DE3) pLysS strain 
of E. coli prior to expression. After 
transformation, the bacteria were grown in LB 
media containing antibiotics (Kanamycin, 30 
ug/mL) at 37 °C until an absorbance of 0.6 - 07 
was observed at 600 nm. Protein expression was 
induced by 1 mM Isopropyl β-D-1-
thiogalactopyranoside (IPTG). After incubation 
for three hours, the cells were centrifuged 
(harvested) at 2500 × g for 30 min at 4 °C. The 
pelleted cells were then stored at -80 °C prior to 
lysis. Four millilitres of bacterial extraction 
reagent (B-PER, Thermo scientific) was added 
per gram of pelleted cells and the suspension 
was pipetted to obtain a homogeneous solution. 
The solution was incubated for 15 min followed 
by centrifugation of lysate for 5 min at 15000 × g 
for separation of soluble protein.  
 
Protein detection was done using sodium 
dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) with Tricine-SDS 
[11]. The protein was purified using Dynabeads® 
His-Tag Isolation & Pulldown (Novex life 
Technologies) according to the manufacture’s 
protocol. The purification method used was 
designed for the isolation of histidine-tagged 
protein by magnetic separation; these 
dynerbeads were coated in a cobalt-based metal 




Trypsin digestion of the expressed protein and 
peptides extraction were carried out according to 
standard methods described by Bringans et al 
[12]. The peptides were analysed by MALDI-
TOF/TOF mass spectrometer using a 5800 
Proteomics Analyzer [AB Sciex].  The resultant 
spectra were identified using Mascot sequence 
matching software [Matrix Science] with 
MSPnr100 Database (MSPnr100 Taxonomy: 
Bacteria (Eubacteria); 45,994,506 sequences) 
accessed in June 2015. 
 
Allergenicity of expressed protein  
 
Allerginecity of protein was determined with 
allergen prediction software 
(http://www.imtech.res.in/raghava/algpred/submi
ssion.html) (Algpred) on the basis of similarity of 
known epitope with any region of protein [13]. 
 
Prediction of antigenicity  
 
Antigenicity predictive value was determined 
using amino acid sequence of the protein with 
the help of Vaxijen server, which predicts 
whether a protein can serve as a probable 
antigen or not. Vaxijen prediction has a default 
threshold value of 0.4 and works on the basis of 
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auto cross covariance (ACC) (http://www.ddg-
pharmfac.net/vaxijen/VaxiJen/VaxiJen.html). 
 
Prediction of MHC class I and MHC class II 
binding epitopes 
 
MHC class I binding epitopes were predicted 
using Propred-1 server containing 47 MHC class 
I alleles [14], while  MHC class II binding 
epitopes were predicted using  Propred  server 
having 51 MHC class II allele [15]. The predicted 
epitopes were further analyzed for antigenicity 
value using Vaxijen server. 
 
Antibody epitope prediction  
 
Kolaskar and Tongaonkar antigenicity scale from 
Immune Epitope Database (IEDB) was used to 
predict antibody epitope binding, the method 
utilizes physicochemical properties of amino acid 





Mascot sequence software was used for data 
analysis to determine homology/identity of the 
protein to phenolpthiocerol synthesis polyketide 
synthase I PpSA. The level of significance was 




Restriction digestion  
 
The Myt272-3 recombinant clone was found to 
have an intact plasmid after it was subjected to 
series of stability testing up to ten generations. 
Restriction endonuclease digestion was carried 
out to determine the size of the insert. Double 
digestion of the clone with the two restriction 
enzymes, Bam-HI-HF and KpnI-HF using cut 
smart buffer led to generation of two fragments, 
an insert with approximate size of 113 bp and 
pET30 vector (Figure 1). 
 
Protein expression and purity 
 
SDS-PAGE indicated the presence of Myt272-3 
recombinant protein with the appearance of a 
protein band of approximately 10.58 kDa, as 
shown with red arrow on Figure 2a. This 
molecular weight matches the computed value of 
10.58 kDa using the EXPASY MW bioinformatics 
tool. After purification protocol, the clear band of 
purified his-tag protein was seen, with molecular 
weight approximately similar to the one obtained 





Figure 1:   Agarose gel showing insert size. Lane L is 
GeneRulerTM 1 kb Plus ladder; lane 1 pET30a+-
Myt272-3 plasmid; lane 2 indicates the restriction 
endonuclease restriction fragments formed by double 
digestion using Bam-HI-HF and KpnI-HF 
 
Figure 2: (a) The Expression of His-tag Myt272-3 protein analyzed by SDS-PAGE. Lane L is a CriterionTM 10-20 
% Tris-Tricine protein marker; Lane 1 indicates protein expressed without insert (control); lane 2 shows protein 
expression at 1mM IPTG where red arrow indicates the expressed his-tag protein. Lane 3 is a non-induced 
control. (b)  Purification of His-tag protein on SDS PAGE. Lane L is a BenchMark TM His-tagged   protein standard 
(Novex life Technologies); Lane 1 contains purified His-tag protein 
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Analysis of the spectra using Mascot sequence 
software indicated an identity or extensive 
homology to phenolpthiocerol synthesis 
polyketide synthase I PpSA of M. tuberculosis, 
M. bovis and M. africanus with score values of 
157; individual ion score > 60 is an indication of 
an extensive homology or identity (p < 0.05).  
 
The protein was also found to be identical or 
extensively in homology with multispecies 
polyketide synthase of M. tuberculosis complex 
(p < 0.05) with score value of 157 which is 
261.67 % greater than the reported ion score of 
60. 
 
Allergenicity and antigenicity  
 
Allergen prediction result from AlgPred tool 
indicated that the protein was non-allergen, with 
score value of -1.4238321 [Threshold = -0.4].  
 
In addition, the positive predictive value of the 
protein was 15.19 % (values > 35 indicates 
allergenicity).  
 
The overall antigenicity value of the protein was 
0.4109 (probable antigen) as determined by 
Vaxijen server (threshold value of 0.4). 
 
Predicted MHC class I and MHC class II 
binding epitopes 
 
Propred-I (for MHC I) and Propred (MHC II) were 
used for prediction of T-cell epitopes for the 
Myt272-3 protein. Identification of MHC-binding 
peptides and their subset of T-cell epitopes 
assist in improving our understanding of 
specificity of immune responses; it is also 
important for in discovery of vaccines [17].  
 
MHC class I and class II binding prediction 
results are shown in Tables 1 and 2, 
respectively.  
 
All the alleles showed good match to the protein 
with log scores of all the peptides greater than 
their respective threshold values at 4 %, and 
Vaxijen values greater than 0.4 (Table 1 for MHC 
I).  
 
For MHC II, only alleles DRB1_1304 and 
DRB1_1321 matched the protein sequence, with 
peptide scores greater than their respective 
threshold values, and Vaxijen value ≥ 0.4 (Table 
2). 
 
Antibody epitope prediction 
 
Table 3: The predicted residue scores by Kolaskar 
and Tongaonkar antigenicity with the threshold value 
of 1.0 
 


















































































































As shown in Table 3, and Figure 3 (center yellow 
region), the most possible epitopes predicted for 
antigenic Myt272-3 protein consist of amino 
acids from 48-58 (SRDAVVL-VVLSGEL) with 
score > 1.0. Another possible epitope is from 
amino acids 40-47 (SLADLGV-LADLGVS). 
 
The prediction was also done by ABCpred, 
Artificial neural network based B-cell epitope 
prediction server 
(http://www.imtech.res.in/raghava/abcpred/). This 
indicated that SRDAVVLSGEL (48-58) is the 




Myt272-3 protein was expressed and purified to 
yield a band of approximate MW 10.58 kDa 
which conformed with the MW computed by 
EXPASY MW bioinformatics tool.  The protein 
was found to be a non-allergen. It has been 
reported that a protein can be classified as an 
allergen when it shows > 35 % identity with a 
familiar allergen over a window of 80 amino 
acids, or presence of six 6 contiguous amino 
acids present in a known allergen [18,19].  
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Figure 3: Kolaskar and Tongaonkar antigenicity plot of Myt272-3 recombinant protein withThreshold: 1.0 
(horizontal redline). The yellow colors above the threshold represent higher scores, while green portions indicate 
unfavorable regions in relation to the region of interest 
 
AlgPred is considered one of the web-based 
servers used to predict allergens through their 
amino acid sequences [20]. Protein Blast of the 
query protein sequence also indicated homology 
of 81 % with phenolpthiocerol synthesis 
polyketide synthase I PpSA of M. tuberculosis, 
which is consistent with the results obtained from 
MALDI-TOF. 
 
It has been reported that polyketide synthase is 
involved in the biosynthesis of unique cell 
surface lipids; Mycobacterium tuberculosis cell 
envelope contain the cell surface lipids that link 
the host and the pathogen [21]. Phthiocerol and 
phenolphthiocerol diesters were reported also as 
important virulence factors of the two main 
mycobacterial pathogens (M. tuberculosis and L. 
leprae) in human [22]. The protein blast result 
also indicated non-homology with human protein. 
It is known that vaccines are considered good 
when they do not show homology with human 
proteins, thus eliminating likelihood of their 
triggering on autoimmune response [8]. 
 
In this study, it was found that thirty (30) allelles 
of MHC I bind peptides with binding scores 
higher than the threshold score of each peptide. 
It was also found that antigenicity values of all 
the peptides were above the Vaxijen server 
threshold (0.4). This strongly indicates that 
Myt272-3 protein is a probable antigenic protein 
for development of tuberculosis vaccine. Epitope 
LADLGVSSR at position 41 was found to have 
the highest antigenicity value of (1.2945) among 
all epitopes. This is an indication of maximum 
binding affinity. 
 
The predicted peptides, LLGRTVSPI and 
VVLSGELSE at positions 60 and 51, respectively 
were found to bind eight different MHC II alleles 
with binding scores greater than their respective 
threshold value at 4 %, but further antigenicity 
analysis using Vaxijen scale revealed only 
peptide, VVLSGELSE had antigenicity activity 
with the score of 0.8284 that is higher than the 
threshold score of 0.4.  
 
It has been observed that computational 
predictions of HLA-II binding are inferior when 
compared with their HLA-I counterparts, due to 
factors which include insufficient data used by 
developers of prediction methods for HLA-II 
binding peptides, and the fact that HLA-II 
molecules have relatively permissive binding 
sites for peptide, a property which limits their 
specificities [23]. The prediction of potential B-
cell epitope was carried out via amino acid-based 
method. All epitopes with antigenic value greater 
than the threshold value of 1.0 were considered 
potential antigenic determinants. The results 
show that all the epitopes from position 36 to 69 
satisfied the threshold value requirement for 
antigenicity.  The highest antigenicity scores 
were recorded in three peptides - SRDAVVL, 





Development of efficient and cost-effective 
vaccine can be achieved through 
immunoinformatics-based vaccine design. The 
predicted results obtained in the present work 
provide a guide for practical design of new 
tuberculosis vaccine. In silico analysis of the 
protein reveals that it is a non-allergen with 
antigenic activity. It binds both MHC I and II but 
to a lesser extent with the latter, probably due to 
the fact that computational predictions of HLA-II 
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binding are inferior when compared with their 
HLA- I counterparts. The protein possesses B-
cell epitopes. These predictive findings have 
implications for design and development of 
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